Brazil approves world's first single-dose dengue vaccine

ctvnews.ca

Brazil approved the world's first single-dose dengue vaccine, a historic achievement amid soaring global cases. The Butantan-DV vaccine, authorized for ages 12-59, showed 91.6% efficacy against severe dengue in trials and allows for simpler vaccination campaigns. Dengue, linked to climate change, reached record levels in 2024, with Brazil producing 30 million doses for late 2026.


With a significance score of 6.4, this news ranks in the top 0.1% of today's 29891 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Brazil approves world's first single-dose dengue vaccine | News Minimalist